(CLB) Core Laboratories - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: NL0000200384
CLB: Reservoir Analysis, Well Completions, Production Optimization, Diagnostic Services
Core Laboratories NV is a leading provider of critical reservoir description and production enhancement services to the global oil and gas industry, operating through two primary business segments: Reservoir Description and Production Enhancement. The companys expertise in characterizing petroleum reservoir rock and fluid samples enables clients to optimize production and improve recovery rates. With a strong focus on laboratory-based analytical services and proprietary studies, Core Laboratories supports a range of energy-related activities, including carbon capture and storage, geothermal projects, and mining evaluations.
The companys Production Enhancement segment offers a comprehensive suite of services and products aimed at optimizing well completions, perforations, and stimulations, as well as providing diagnostic services to evaluate the effectiveness of enhanced oil recovery projects. By leveraging its technical expertise and industry knowledge, Core Laboratories helps clients improve the efficiency and productivity of their operations. With a global presence and a history dating back to 1936, the company has established itself as a trusted partner to the energy industry.
From a technical analysis perspective, CLBs current price is below its 20-day and 50-day simple moving averages, indicating a potential downtrend. The stocks 52-week high and low are $24.43 and $10.59, respectively, with the current price near the lower end of this range. The Average True Range (ATR) is 0.89, representing a 7.67% volatility. Using this data, we can forecast that CLB may face resistance around $12.50, with potential support at $10.50. A break above $12.50 could signal a bullish reversal, while a drop below $10.50 may indicate further downside.
Fundamentally, CLBs market capitalization is approximately $578.54 million, with a forward price-to-earnings ratio of 19.76. The companys return on equity is 11.19%, indicating a relatively stable financial performance. By combining this fundamental data with the technical analysis, we can forecast that CLBs stock price may stabilize around $12.00 in the near term, driven by its relatively stable earnings and the potential for increased demand in the energy services sector. However, a sustained recovery above $15.00 would require a significant improvement in industry conditions and the companys financial performance.
Additional Sources for CLB Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CLB Stock Overview
Market Cap in USD | 579m |
Sector | Energy |
Industry | Oil & Gas Equipment & Services |
GiC Sub-Industry | Oil & Gas Equipment & Services |
IPO / Inception | 1995-09-20 |
CLB Stock Ratings
Growth Rating | -46.7 |
Fundamental | 33.3 |
Dividend Rating | 12.8 |
Rel. Strength | -25.3 |
Analysts | 3/5 |
Fair Price Momentum | 9.07 USD |
Fair Price DCF | 11.94 USD |
CLB Dividends
Dividend Yield 12m | 0.27% |
Yield on Cost 5y | 0.22% |
Annual Growth 5y | -32.24% |
Payout Consistency | 87.1% |
CLB Growth Ratios
Growth Correlation 3m | -84.4% |
Growth Correlation 12m | -57.5% |
Growth Correlation 5y | -52.6% |
CAGR 5y | -9.47% |
CAGR/Max DD 5y | -0.12 |
Sharpe Ratio 12m | -0.66 |
Alpha | -45.91 |
Beta | 1.457 |
Volatility | 64.79% |
Current Volume | 1321.1k |
Average Volume 20d | 587.4k |
As of May 09, 2025, the stock is trading at USD 11.10 with a total of 1,321,051 shares traded.
Over the past week, the price has changed by -4.89%, over one month by +4.80%, over three months by -35.38% and over the past year by -32.32%.
Neither. Based on ValueRay Fundamental Analyses, Core Laboratories is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 33.28 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CLB as of May 2025 is 9.07. This means that CLB is currently overvalued and has a potential downside of -18.29%.
Core Laboratories has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold CLB.
- Strong Buy: 0
- Buy: 1
- Hold: 3
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, CLB Core Laboratories will be worth about 10.3 in May 2026. The stock is currently trading at 11.10. This means that the stock has a potential downside of -7.48%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 16.4 | 47.7% |
Analysts Target Price | 16.4 | 47.7% |
ValueRay Target Price | 10.3 | -7.5% |